|
Originally published In Press as doi:10.1074/jbc.M202053200 on March 27, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21759-21767, June 14, 2002
Biochemical Defects in Retina-specific Human ATP Binding Cassette
Transporter Nucleotide Binding Domain 1 Mutants Associated with Macular
Degeneration*
Tatiana
Suárez ,
Subhasis B.
Biswas§, and
Esther E.
Biswas ¶
From the Department of Laboratory Sciences, Program
in Biotechnology, Thomas Jefferson University, Philadelphia,
Pennsylvania 19107 and the § Department of Molecular
Biology, School of Osteopathic Medicine & Graduate School of Biomedical
Sciences, University of Medicine and Dentistry of New Jersey,
Stratford, New Jersey 08043
The retina-specific human ABC
transporter (ABCR) functions in the retinal transport system and has
been implicated in several inherited visual diseases, including
Stargardt disease, fundus flavimaculatus, cone-rod dystrophy, and
age-related macular degeneration. We have previously described a
general ribonucleotidase activity of the first nucleotide binding
domain (NBD1) of human ABCR (Biswas, E. E. (2001)
Biochemistry 40, 8181-8187). In this communication, we
present a quantitative study analyzing the effects of certain disease-associated mutations, Gly-863 Ala, Pro-940 Arg, and Arg-943 Gln on the nucleotide binding, and general
ribonucleotidase activities of this domain. NBD1 proteins, harboring
these mutations, were created through in vitro
site-specific mutagenesis and expressed in Escherichia
coli. Results of the enzyme-kinetic studies indicated that these
mutations altered the ATPase and CTPase activities of NBD1. The G863A
and P940R mutations were found to have significant attenuation of the
rates of nucleotide hydrolysis and binding affinities. On the other
hand, the R943Q mutation had small, but detectable reduction in its
nucleotidase activity and nucleotide binding affinity. We have measured
the nucleotide binding affinities of NBD1 protein and its mutants
quantitatively by fluorescence anisotropy changes during protein
binding to ethenoadenosine ATP ( ATP), a fluorescent ATP
analogue. We have correlated the dissociation constant
(KD) and the rates of nucleotide hydrolysis (Vmax) of NBD1 and its mutants with the
available genetic data for these mutations.
*
This work was supported by Grant EY13113-01 from the
National Eye Institute (to E. E. B.), by Fight for Sight Research
Division of Prevent Blindness America Inc. Grant GA20048 (to
E. E. B.), and by NIGMS, National Institutes of Health Grant
GM36002-13 (to S. B. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Laboratory Sciences, Program in Biotechnology, Thomas Jefferson
University, Philadelphia, PA 19107. Tel.: 215-503-8184; Fax:
781-207-8476; E-mail: esther.biswas@mail.tju.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Valverde, R. Riveiro-Alvarez, J. Aguirre-Lamban, M. Baiget, M. Carballo, G. Antinolo, J. M. Millan, B. G. Sandoval, and C. Ayuso
Spectrum of the ABCA4 Gene Mutations Implicated in Severe Retinopathies in Spanish Patients
Invest. Ophthalmol. Vis. Sci.,
March 1, 2007;
48(3):
985 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|